Identification |
Name: | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-,sodium salt (1:1), (2S,5R,6R)- |
Synonyms: | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-,monosodium salt (8CI); 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-,monosodium salt, (2S,5R,6R)- (9CI);4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-,monosodium salt, [2S-(2a,5a,6b)]-;3-(o-Chlorophenyl)-5-methyl-4-isoxazolylpenicillin sodium salt; Ankerbin;Austrastaph; BRL 1621 sodium salt; Cloxacillin sodium; Cloxacillin sodium salt;Cloxapen; Ekvacillin; Gelstaph; Monosodium cloxacillin; Orbenin; Orbeninsodium; Prevencilina P; Prostaphilin A; Prostaphlin A; Sodium3-(O-chlorophenyl)-5-methyl-4-isoxazolylpenicillin; Sodium cloxacillin; Sodiumorbenin; Sodium syntarpen; Staphybiotic; Syntarpen sodium salt; Tegopen |
CAS: | 642-78-4 |
EINECS: | 211-390-9 |
Molecular Formula: | C19H18 Cl N3 O5 S . Na |
Molecular Weight: | 457.86315 |
InChI: | InChI=1S/C19H18ClN3O5S.Na/c1-8-11(12(22-28-8)9-6-4-5-7-10(9)20)15(24)21-13-16(25)23-14(18(26)27)19(2,3)29-17(13)23;/h4-7,13-14,17H,1-3H3,(H,21,24)(H,26,27);/q;+1/p-1/t13-,14+,17-;/m1./s1 |
Molecular Structure: |
|
Properties |
Stability: | Stable. Incompatible with strong oxidizing agents. Refrigerate. |
Water Solubility: | 50 mg/ml Stability Stable. Incompatible with strong oxidizing agents. Refrigerate. Toxicology May be harmful or act as an irritant - toxicologynot fully investigated. Toxicity da |
Solubility: | 50 mg/ml |
Appearance: | white powder |
Specification: |
? Cloxacillin sodium?with CAS registry number of 642-78-4 is a semisynthetic antibiotic in the same class as penicillin, also called for 3-o-Chlorophenyl-5-methyl-4-isoxazolylpenicillin sodium ; Ankerbin ; Austrastaph ; BRL 1621 sodium salt ; BRL-1621 sodium salt ; Cloxacillin sodium anhydrous ; Cloxapen ; Ekvacillin ; Gelstaph ; Monosodium cloxacillin ; Orbenin sodium ; Prevencilina P ; Prostaphilin A ; Prostaphlin A ; Sodium 3-(o-chlorophenyl)-5-methyl-4-isoxazolylpenicillin ; Sodium cloxacillin ; Sodium orbenin ; Sodium syntarpen ; Staphybiotic ; Syntarpen sodium salt ; Tegopen ; UNII-MWQ645MKMF ; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(3-(2-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-, monosodium salt, (2S,5R,6R)- ; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(3-(2-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-, monosodium salt, (2S-(2alpha,5alpha,6beta))- ; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-, monosodium salt . Cloxacillin was discovered and developed by Beecham. It is sold under a number of trade names such as?Cloxapen and Orbenin. It?is used against staphylococci but has a weaker antibacterial activity than benzylpenicillin, and is devoid of serious toxicity except for allergic reactions. It has been suggested that increased use of cloxacillin may permit reduced use of vancomycin.
|
Usage: | Cloxacillin is an antibiotic that belongs to the group of the isoxazolylpenicillins. Cloxacillin is used to treat infections caused by species of staphylococci that produce beta-lactamase due to its inhibitory effects on beta-lactamase binding. |
Safety Data |
|
|